FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
Medical Marketing & Media

Two new Untitled Letters, multiple close-outs: Latest on FDA’s pharma ad crackdown

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...

How to spot suspicious health supplements and avoid getting scammed

Snopes readers regularly ask whether supplement brands like Neurocept and Burn Peak are legit. Here's how you can tell yourself.